Oragenics, Inc. (OGEN)
NYSEAMERICAN: OGEN · Real-Time Price · USD
0.612
-0.018 (-2.90%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Oragenics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | - | - | 0.04 | 0.13 | 0.09 | Upgrade
|
| Revenue Growth (YoY) | - | - | -71.37% | 51.20% | - | Upgrade
|
| Cost of Revenue | 2.39 | 4.11 | 15.49 | 10.07 | 10.59 | Upgrade
|
| Gross Profit | -2.39 | -4.11 | -15.45 | -9.94 | -10.5 | Upgrade
|
| Selling, General & Admin | 6.97 | 6.44 | 5.45 | 4.48 | 5.27 | Upgrade
|
| Other Operating Expenses | - | - | - | - | 0 | Upgrade
|
| Operating Expenses | 6.97 | 6.44 | 5.45 | 4.48 | 5.27 | Upgrade
|
| Operating Income | -9.36 | -10.56 | -20.9 | -14.42 | -15.77 | Upgrade
|
| Interest Expense | -0.79 | -0.03 | -0.03 | -0.02 | -0.02 | Upgrade
|
| Interest & Investment Income | 0.18 | 0.05 | 0.21 | 0.14 | 0.08 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.01 | -0.03 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | 0.07 | 0.01 | 0 | Upgrade
|
| EBT Excluding Unusual Items | -9.98 | -10.57 | -20.66 | -14.29 | -15.71 | Upgrade
|
| Pretax Income | -9.98 | -10.57 | -20.66 | -14.29 | -15.71 | Upgrade
|
| Income Tax Expense | -0.14 | - | - | - | - | Upgrade
|
| Earnings From Continuing Operations | -9.84 | -10.57 | -20.66 | -14.29 | -15.71 | Upgrade
|
| Net Income | -9.84 | -10.57 | -20.66 | -14.29 | -15.71 | Upgrade
|
| Net Income to Common | -9.84 | -10.57 | -20.66 | -14.29 | -15.71 | Upgrade
|
| Shares Outstanding (Basic) | 2 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 2 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 877.24% | 194.38% | 11.97% | 3.40% | 106.24% | Upgrade
|
| EPS (Basic) | -4.56 | -47.88 | -275.48 | -213.36 | -242.59 | Upgrade
|
| EPS (Diluted) | -4.56 | -47.88 | -275.48 | -213.36 | -242.59 | Upgrade
|
| Free Cash Flow | -9.25 | -8.6 | -7.29 | -15.36 | -13.51 | Upgrade
|
| Free Cash Flow Per Share | -4.29 | -38.95 | -97.23 | -229.30 | -208.66 | Upgrade
|
| Operating Margin | - | - | -55519.89% | -10964.61% | -18131.88% | Upgrade
|
| Profit Margin | - | - | -54858.14% | -10863.96% | -18062.03% | Upgrade
|
| Free Cash Flow Margin | - | - | -19363.34% | -11675.70% | -15535.76% | Upgrade
|
| EBITDA | - | -10.53 | -20.88 | -14.38 | -15.73 | Upgrade
|
| D&A For EBITDA | - | 0.03 | 0.03 | 0.04 | 0.04 | Upgrade
|
| EBIT | -9.36 | -10.56 | -20.9 | -14.42 | -15.77 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.